StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Charles River Laboratories International's price to sales ratio was 4.1× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.5× to 5.5×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.1×+1.7
2025Dec 31, 20252.4×+0.1
2024Dec 31, 20242.3×−0.6
2023Dec 29, 20232.9×−0.1
2022Dec 30, 20222.9×−2.6
2021Dec 31, 20215.5×+1.1
2020Dec 31, 20204.4×+1.5
2019Dec 31, 20192.9×+0.4
2018Dec 31, 20182.5×−0.3
2017Dec 29, 20172.8×+0.5
2016Dec 30, 20162.3×−0.5
2015Dec 31, 20152.8×+0.4
2014Dec 31, 20142.4×+0.4
2013Jul 31, 20131.9×+0.3
2012Dec 31, 20121.6×+0.4
2011Dec 30, 20111.2×−0.6
2010Dec 31, 20101.8×–

More Charles River Laboratories International figures

See a number that looks wrong?